Gastroenterology
Volume 138, Issue 5 , Pages 1854-1862.e1, May 2010

Aberrant DNA Methylation in Hereditary Nonpolyposis Colorectal Cancer Without Mismatch Repair Deficiency

  • Ajay Goel

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Baylor University, Medical Center, Dallas, Texas
    • Corresponding Author InformationAjay Goel, PhD, Gastointestinal Research Lab, Baylor University Medical Center, 3500 Gaston Avenue, Suite H-250, Dallas, Texas 75246. fax: (214) 818-9292
  • ,
  • Rosa M. Xicola

      Affiliations

    • Department of Medicine and Cancer Center, University of Illinois at Chicago, Chicago, Illinois
  • ,
  • Thuy–Phuong Nguyen

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Baylor University, Medical Center, Dallas, Texas
  • ,
  • Brian J. Doyle

      Affiliations

    • Department of Medicine and Cancer Center, University of Illinois at Chicago, Chicago, Illinois
  • ,
  • Vanessa R. Sohn

      Affiliations

    • Department of Medicine and Cancer Center, University of Illinois at Chicago, Chicago, Illinois
  • ,
  • Prathap Bandipalliam

      Affiliations

    • Division of Population Sciences, Dana-Farber Cancer Institute and Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts
  • ,
  • Laura S. Rozek

      Affiliations

    • School of Public Health, University of Michigan, Ann Arbor, Michigan
  • ,
  • Josep Reyes

      Affiliations

    • Gastroenterology Department, Hospital Comarcal Inca, Mallorca, Spain
  • ,
  • Carmen Cordero

      Affiliations

    • Gastroenterology Department, Hospital Virgen del Rocio, Sevilla, Spain
  • ,
  • Francesc Balaguer

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Baylor University, Medical Center, Dallas, Texas
  • ,
  • Antoni Castells

      Affiliations

    • Gastroenterology Department, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Catalonia, Spain
  • ,
  • Rodrigo Jover

      Affiliations

    • Gastroenterology Unit, Hospital General Univ, Alicante, Spain
  • ,
  • Montserrat Andreu

      Affiliations

    • Gastroenterology Department, Hospital del Mar, Barcelona, Catalonia, Spain
  • ,
  • Sapna Syngal

      Affiliations

    • Division of Population Sciences, Dana-Farber Cancer Institute and Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts
  • ,
  • C. Richard Boland

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Baylor University, Medical Center, Dallas, Texas
  • ,
  • Xavier Llor

      Affiliations

    • Department of Medicine and Cancer Center, University of Illinois at Chicago, Chicago, Illinois
    • Corresponding Author InformationReprint requests Address requests for reprints to: Xavier Llor, MD, PhD, Department of Medicine and Cancer Center, University of Illinois at Chicago, 840 South Wood Street (M/C 716), Chicago, Illinois 60612. fax: (312) 996-5103

Received 12 October 2009; accepted 8 January 2010. published online 25 January 2010.

Background & Aims

Approximately half of the families that fulfill Amsterdam criteria for Lynch syndrome or hereditary nonpolyposis colorectal cancer (HNPCC) do not have evidence of the germline mismatch repair gene mutations that define this syndrome and result in microsatellite instability (MSI). The carcinogenic pathways and the best diagnostic approaches to detect microsatellite stable (MSS) HNPCC tumors are unclear. We investigated the contribution of epigenetic alterations to the development of MSS HNPCC tumors.

Methods

Colorectal cancers were divided into 4 groups: (1) microsatellite stable, Amsterdam-positive (MSS HNPCC) (N = 22); (2) Lynch syndrome cancers (identified mismatch repair mutations) (N = 21); (3) sporadic MSS (N = 92); and (4) sporadic MSI (N = 46). Methylation status was evaluated for CACNAG1, SOCS1, RUNX3, NEUROG1, MLH1, and long interspersed nucleotide element-1 (LINE-1). KRAS and BRAF mutation status was analyzed.

Results

MSS HNPCC tumors displayed a significantly lower degree of LINE-1 methylation, a marker for global methylation, than any other group. Although most MSS HNPCC tumors had some degree of CpG island methylation, none presented a high index of methylation. MSS HNPCC tumors had KRAS mutations exclusively in codon 12, but none harbored V600E BRAF mutations.

Conclusions

Tumors from Amsterdam-positive patients without mismatch repair deficiency (MSS HNPCC) have certain molecular features, including global hypomethylation, that distinguish them from all other colorectal cancers. These characteristics could have an important impact on tumor behavior or treatment response. Studies are underway to further assess the cause and effects of these features.

Keywords: Colorectal Cancer, Microsatellite Stable, Hereditary Nonpolyposis Colorectal Cancer, Non-Lynch HNPCC

Abbreviations used in this paper: CIMP, CpG island methylation phenotype, CRC, colorectal cancer, HNPCC, hereditary nonpolyposis colorectal cancer, LINE-1, long interspersed nucleotide element-1, MI, methylation index, MMR, mismatch repair, MSI, microsatellite instability, MSS, microsatellite stable, PCR, polymerase chain reaction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by the Sirazi Foundation, Raymond Cole Memorial Foundation, and an internal grant from the Department of Medicine and the Cancer Center of the University of Illinois at Chicago (X.L.); National Institutes of Health grants CA72851 and funds from the Baylor Research Institute (C.R.B. and A.G.); and a grant from the Spanish Ministerio de Ciencia e Innovación (SAF 07-64873 to A.C.).

PII: S0016-5085(10)00102-2

doi:10.1053/j.gastro.2010.01.035

Gastroenterology
Volume 138, Issue 5 , Pages 1854-1862.e1, May 2010